학술논문

Multivalent in vivo delivery of DNA-encoded bispecific T cell engagers effectively controls heterogeneous GBM tumors and mitigates immune escape
Document Type
Article
Source
In Molecular Therapy - Oncolytics 16 March 2023 28:249-263
Subject
Language
ISSN
2372-7705